TopFunds

McKesson Corporation

NYSE: MCK

Stock price

1004.84 USD

(+0%) TODAY

Medical - Distribution
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
9.7
22.7
0.3
0.2
5
(27)
7.2
25
22.4
25.7
38.4
14.7%
02Free cash flow per share
12.9
18.8
18
17.6
21.3
24.3
25.3
32.4
27
40.8
43.6
13%
03Dividends per share
1.1
1.1
1.3
1.5
1.6
1.7
1.8
2.1
2.4
2.8
3.2
11.4%
04Dividends payout, %
10.8%
4.9%
3.9%
8.6%
32.7%
(6.1)%
24.9%
8.2%
10.5%
10.5%
8%
(3)%
PROFIT AND LOSS STATEMENT
05Revenue
190,884
198,533
208,357
214,319
231,051
238,228
263,966
276,711
308,951
359,051
403,430
7.8%
06% Change
-
-
-
-
-
-
-
-
-
-
-
7.8%
07Cost of revenue
(179,941)
(187,845)
(197,965)
(203,557)
(219,651)
(226,646)
(251,317)
(264,842)
(296,749)
(346,566)
(388,880)
8%
08Gross profit
10,943
10,688
10,392
10,762
11,400
11,582
12,649
11,869
12,202
12,485
14,550
2.9%
09% Margin
5.7%
5.4%
5%
5%
4.9%
4.9%
4.8%
4.3%
4%
3.5%
3.6%
4.6% A
10Operating expenses
(7,092)
(7,331)
(7,471)
(7,684)
(8,388)
(8,072)
(9,926)
(7,416)
(8,275)
(8,113)
(8,096)
1.3%
11% of Revenue
(3.7)%
(3.7)%
(3.6)%
(3.6)%
(3.6)%
(3.4)%
(3.8)%
(2.7)%
(2.7)%
(2.3)%
(2)%
(3.2)% A
12Operating Income
3,851
3,357
2,921
3,078
3,012
3,510
2,723
4,453
3,927
4,372
6,454
5.3%
13Income tax expense
(908)
(1,614)
(53)
(356)
(18)
(695)
(636)
(905)
(629)
(878)
(1,102)
2%
14Net Income
2,258
5,183
67
34
900
(4,539)
1,114
3,560
3,002
3,295
4,762
7.8%
15% Margin
1.2%
2.6%
-
-
0.4%
(1.9)%
0.4%
1.3%
1%
0.9%
1.2%
0.7% A
16Shares Outstanding
233
223
209
197.3
182
160.6
154.1
142.2
134.1
128.1
124.1
(6.1)%
17EPS Basic
9.8
23
0.3
0.2
5
(27)
7.3
25.2
22.5
25.9
38.6
14.7%
18EPS Diluted
9.7
22.7
0.3
0.2
5
(27)
7.2
25
22.4
25.7
38.4
14.7%
19EBITDA
4,488
8,109
1,473
1,823
2,315
(3,930)
2,866
5,486
4,667
5,251
7,177
4.8%
% Margin
2.4%
4.1%
0.7%
0.9%
1%
(1.7)%
1.1%
2%
1.5%
1.5%
1.8%
1.4% A
20Net Interest Income (expense)
(335)
(279)
(235)
(225)
(200)
(205)
(168)
(141)
(125)
(83)
(68)
(14.7)%
21Net Debt / EBITDA
0.9
0.7
3.5
2.5
2.3
(0.8)
1.4
0.5
0.6
0.3
0.6
1.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
4,048
2,783
2,672
2,981
4,015
6,278
3,532
4,678
4,583
5,691
3,975
(0.2)%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
17,980
18,215
17,711
18,246
19,950
19,181
18,583
19,410
21,622
25,643
27,985
4.5%
25Other current assets
1,072
672
443
529
1,523
677
5,414
513
626
1,063
1,043
(0.3)%
26Inventory
15,335
15,278
16,310
16,709
16,734
19,246
18,702
19,691
21,139
23,001
24,207
4.7%
27Total Current Assets
38,437
36,948
37,136
38,465
42,222
45,382
46,231
44,292
47,970
55,398
57,210
4.1%
Non-Current Assets
28Net property, plant & equipment
2,278
2,292
2,464
2,548
4,251
4,681
3,640
3,812
4,045
4,284
4,726
7.6%
29Long-term investments
-
4,063
3,728
3,513
170
72
-
312
348
-
267
-
30Other non-current assets
15,848
17,666
17,053
15,146
14,604
14,880
13,427
13,904
15,080
15,458
20,120
2.4%
31Total Non-Current Assets
18,126
24,021
23,245
21,207
19,025
19,633
17,067
18,028
19,473
19,742
25,113
3.3%
Total Assets
56,563
60,969
60,381
59,672
61,247
65,015
63,298
62,320
67,443
75,140
82,323
3.8%
LIABILITIES
Current Liabilities
32Accounts payable
28,585
31,022
32,177
33,853
37,195
38,975
38,086
42,490
47,097
55,330
59,973
7.7%
33Short-term debt
(2,159)
(1,693)
(2,062)
330
1,406
1,132
1,096
1,267
345
1,449
1,554
-
34Other current liabilities
8,645
6,283
6,570
3,443
4,023
3,996
9,284
4,200
4,915
4,825
5,490
(4.4)%
35Total Current Liabilities
35,071
35,612
36,685
37,626
42,624
44,103
48,466
47,957
52,357
61,604
67,017
6.7%
Non-Current Liabilities
36Long-term debt
6,497
7,305
6,751
7,308
7,995
8,273
6,446
6,028
7,045
5,941
7,060
0.8%
37Other non-current liabilities
4,581
5,452
5,429
5,058
3,917
11,193
10,178
9,825
9,640
9,289
9,080
7.1%
38Total Non-Current Liabilities
11,078
12,757
12,180
12,366
11,912
19,466
16,624
15,853
16,685
15,230
16,140
3.8%
39Total Liabilities
46,149
48,369
48,865
49,992
54,536
63,569
65,090
63,810
69,042
76,834
83,157
6.1%
SHAREHOLDERS` EQUITY
40Common stock
3
3
3
3
2
2
2
3
3
3
3
-
41Retained earnings / (deficit)
8,360
13,189
12,986
12,409
13,022
8,202
9,030
12,295
14,978
17,921
22,291
10.3%
42Accumulated other comprehensive income / (loss)
(1,561)
(2,141)
(1,717)
(1,849)
(1,703)
(1,480)
(1,534)
(905)
(881)
(932)
(1,453)
(0.7)%
43Noncontrolling interests
1,490
1,505
1,712
1,586
1,619
1,467
480
367
372
380
1,338
(1.1)%
44Total shareholders' equity
10,414
12,600
11,516
9,680
6,711
1,446
(1,792)
(1,490)
(1,599)
(1,694)
(834)
-
45Total Liabilities and shareholders' Equity
56,563
60,969
60,381
59,672
61,247
65,015
63,298
62,320
67,443
75,140
82,323
3.8%
46Total Debt
8,154
8,545
7,880
7,595
9,401
9,405
7,542
7,295
7,390
7,390
8,614
0.6%
47Net Debt
4,106
5,762
5,208
4,614
5,386
3,127
4,010
2,617
2,807
1,699
4,639
1.2%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
2,258
5,183
67
34
900
(4,539)
1,114
3,560
3,002
3,295
4,762
7.8%
49Depreciation & amortization
885
910
951
949
922
887
760
608
635
636
729
(1.9)%
50Share-based compensation expense
123
115
69
-
-
-
161
162
-
-
-
-
51Changes in working capital and other assets
406
(1,464)
3,258
3,053
2,552
8,194
2,399
829
677
2,154
664
5%
52Net cash flows from operating activities
3,672
4,744
4,345
4,036
4,374
4,542
4,434
5,159
4,314
6,085
6,155
5.3%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(677)
(562)
(580)
(557)
(506)
(641)
(535)
(558)
(431)
(537)
(745)
1%
54Purchases of investments / marketable securities
(399)
(506)
(6)
(146)
(70)
(391)
(446)
-
-
-
-
-
55Proceeds from maturities of marketable securities
210
-
(169)
15
70
391
446
866
-
-
-
-
56Other investing activities
(691)
(2,728)
(767)
(693)
(73)
226
446
(850)
(641)
(196)
(2,687)
14.6%
57Net cash flows from investing activities
(1,557)
(3,796)
(1,522)
(1,381)
(579)
(415)
(89)
(542)
(1,072)
(733)
(3,432)
8.2%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(1,489)
(2,191)
(1,577)
(1,564)
(1,821)
(650)
(3,296)
(3,475)
(2,909)
(3,045)
(4,661)
12.1%
59Dividends paid, net
(244)
(253)
(262)
(292)
(294)
(276)
(277)
(292)
(314)
(345)
(381)
4.6%
60Debt issuance (repayments), net
(1,725)
393
(948)
(16)
(298)
(540)
(1,150)
(277)
56
(21)
783
-
61Other financing activities
5
(18)
(297)
(355)
(321)
(227)
(1,598)
(324)
(175)
(554)
(372)
-
62Net cash flows from financing activities
(3,453)
(2,069)
(3,084)
(2,227)
(2,734)
(1,693)
(6,321)
(4,368)
(3,342)
(3,965)
(4,631)
3%
63Increase (decrease) in cash and cash equivalents
(1,293)
(1,265)
(111)
309
1,042
2,381
(2,461)
744
(94)
1,371
(1,981)
4.4%
64Cash and equivalents, ending balance
4,048
2,783
2,672
2,981
4,023
6,396
3,935
4,679
4,583
5,956
3,975
(0.2)%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
2,995
4,182
3,765
3,479
3,868
3,901
3,899
4,601
3,883
5,548
5,410
6.1%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2026202520242023202220212020201920182017

McKesson Corporation (MCK) financial statements and performance

Explore McKesson Corporation (MCK) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.